Featured Research

from universities, journals, and other organizations

Flight Stockings Significantly Reduce DVT Risk, Says Research Review

Date:
June 15, 2005
Source:
Blackwell Publishing Ltd.
Summary:
People who don't wear graduated compression stockings when they fly are more than 12 times more likely to develop Deep Vein Thrombosis (DVT) than those who do, according to a research review published in the latest Journal of Advanced Nursing. Researchers analysed the results of nine comparative trials carried out in the UK and Italy on nearly 2,500 flyers over a two-year period.

People who don't wear graduated compression stockings when they fly are more than 12 times more likely to develop Deep Vein Thrombosis (DVT) than those who do, according to a research review published in the latest Journal of Advanced Nursing.

Researchers analysed the results of nine comparative trials carried out in the UK and Italy on nearly 2,500 flyers over a two-year period.

Each study contained a group wearing knee-length graduated compression stockings and a control group who did not wear the stockings.

They discovered that only two of the 1,237 participants wearing the stockings developed DVT compared with 46 of the 1,245 people in the control groups.

Having carried out a detailed weighted analysis of the results and the factors examined in each of the nine studies, the authors concluded that a passenger not wearing graduated compressions stockings was 12.5 times more likely to develop DVT.

All the participants who took part in the studies were also advised to walk or exercise regularly, drink water, avoid salty food and make sure that bulky baggage didn't restrict their leg movement.

"The risk of venous thrombosis was first recognised in 1940 when 21 people died from pulmonary embolisms after prolonged sitting in air raid shelters in London" points out co-author Professor Hsiu-Fang Hsieh from Fooyin University in Taiwan.

"However, it wasn't until 1954 that researchers first suggested the link between long-haul air travel and DVT. Since then it has become more common for people to travel long distances by air and concern about the risks of DVT have increased."

Graduate compression stockings may be a relatively new concept for air travellers, but they have been around for thousands of years, according to Professor Hsieh.

"There is evidence that the ancient Egyptians recognised the benefit of leggings that applied greater pressure at the ankle than at the knee" she says.

"Our research review shows that the modern-day equivalent is a useful way of reducing the risk of DVT when flying, particularly on long-haul flights. They are also easy to use and have no side effects.

"However, travellers should not see wearing the stockings as a substitute for following sensible advice, like moving regularly and avoiding dehydration."

The review found that although the stockings reduced the risk of DVT, they did little to reduce the incidence of superficial venous thrombosis in low, medium or high risk participants.

There was a slight difference between the stocking wearing and control groups -- 0.48 per cent versus 0.85 per cent respectively -- but this was not statistically significant.

"There have been a number of research studies into DVT and how flyers can counteract the risks" adds Professor Alison Tierney, Editor-in-Chief of the Journal of Advanced Nursing. "This research review provides a useful overview of some of the most recent comparative research on more than 2,500 flyers, which is why we were so keen to publish it.

"I personally believe that graduated compression stockings are essential for anyone travelling on long-haul flights. As a frequent traveller to Australia, I certainly wouldn't leave home without them!"


Story Source:

The above story is based on materials provided by Blackwell Publishing Ltd.. Note: Materials may be edited for content and length.


Cite This Page:

Blackwell Publishing Ltd.. "Flight Stockings Significantly Reduce DVT Risk, Says Research Review." ScienceDaily. ScienceDaily, 15 June 2005. <www.sciencedaily.com/releases/2005/06/050615061836.htm>.
Blackwell Publishing Ltd.. (2005, June 15). Flight Stockings Significantly Reduce DVT Risk, Says Research Review. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2005/06/050615061836.htm
Blackwell Publishing Ltd.. "Flight Stockings Significantly Reduce DVT Risk, Says Research Review." ScienceDaily. www.sciencedaily.com/releases/2005/06/050615061836.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins